Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.45 USD | +7.19% | -4.73% | -39.13% |
May. 09 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
May. 07 | Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
411M | - | - | - | - | - | |
226B | ||||||
188B | ||||||
137B | ||||||
108B | ||||||
63.19B |